Auris Medical (EARS) Priced

Biotech developing treatments for tinnitus and other inner ear disorders.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $0.85 0.00 (0.0%)
First Day Return 0.0%
Return from IPO -85.8%
 
Auris Medical IPO News more
  • .
IPO Data
IPO File Date 06/30/2014
Offer Price $6.00
Price Range $6.00 - $6.00
Offer Shares (mm) 9.4
Deal Size ($mm) 56
 
IPO Data
IPO Date 08/05/2014
Offer Price $6.00
Price Range $6.00 - $6.00
Offer Shares (mm) 9.4
Deal Size ($mm) $56
 
Underwriters
more
Business Overview
Biotech developing treatments for tinnitus and other inner ear disorders.
Biotech developing treatments for tinnitus and other inner ear disorders.
more
Company Data
Headquarters Zug, , Switzerland
Founded 2003
Employees 13
Website www.aurismedical.com
 

Performance vs. IPO Index (IPOUSA)